Intranasal Ketamine Confers Rapid Antidepressant Effect in Depression

A research team from the Icahn School of Medicine at Mount Sinai published the first controlled evidence showing that an intranasal ketamine spray conferred an unusually rapid antidepressant effect -within 24 hours--and was well tolerated in patients with treatment-resistant major depressive disorder.

Read the whole article on Newswise - Scinews

More from Newswise - Scinews